Biomunex
  • HOME
  • COMPANY
    • ABOUT BIOMUNEX
    • TEAM
    • STRATEGIC BOARD AND KEY ADVISORS
    • FUNDING AND GRANTS
  • TECHNOLOGIES AND PRODUCTS
    • ANTIBODY THERAPEUTICS
    • BiXAb® TECHNOLOGY
    • BI- AND MULTI-SPECIFIC ANTIBODIES DEVELOPED BY BIOMUNEX
    • PIPELINE
    • INTELLECTUAL PROPERTY
    • PUBLICATIONS AND PRESENTATIONS
  • PARTNERING
    • ACADEMIC AND INSTITUTIONAL COLLABORATIONS
    • INDUSTRIAL PARTNERSHIP AGREEMENTS
    • DEVELOPMENT AND LICENSE AGREEMENTS
    • MEET US
  • CAREERS
  • NEWS
    • PRESS RELEASES
    • MEDIA
  • CONTACT
Menu Fermer
  • HOME
  • COMPANY
    • ABOUT BIOMUNEX
    • TEAM
    • STRATEGIC BOARD AND KEY ADVISORS
    • FUNDING AND GRANTS
  • TECHNOLOGIES AND PRODUCTS
    • ANTIBODY THERAPEUTICS
    • BiXAb® TECHNOLOGY
    • BI- AND MULTI-SPECIFIC ANTIBODIES DEVELOPED BY BIOMUNEX
    • PIPELINE
    • INTELLECTUAL PROPERTY
    • PUBLICATIONS AND PRESENTATIONS
  • PARTNERING
    • ACADEMIC AND INSTITUTIONAL COLLABORATIONS
    • INDUSTRIAL PARTNERSHIP AGREEMENTS
    • DEVELOPMENT AND LICENSE AGREEMENTS
    • MEET US
  • CAREERS
  • NEWS
    • PRESS RELEASES
    • MEDIA
  • CONTACT
Skip to content
Lire la suite à propos de l’article Antibody Biotherapeutics
CANCER AND BISPECIFIC ANTIBODY THERAPIES

Antibody Biotherapeutics

  • Auteur/autrice de la publication :biomunex
  • Post published:17 septembre 2017
  • Post category:

Continuer la lectureAntibody Biotherapeutics
Lire la suite à propos de l’article Cancer
BIOMUNEX BiXAb® PLATFORM

Cancer

  • Auteur/autrice de la publication :biomunex
  • Post published:8 juin 2016
  • Post category:

Continuer la lectureCancer
Lire la suite à propos de l’article Pipeline
PIPELINE

Pipeline

  • Auteur/autrice de la publication :biomunex
  • Post published:28 avril 2016
  • Post category:

Continuer la lecturePipeline

CONTACT

CAREERS

PRIVACY POLICY BIOMUNEX

LEGAL INFORMATION